NCT00279032View on ClinicalTrials.gov

GW406381 In Patients With Peripheral Nerve Injury

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

September 30, 2003

Conditions

HyperalgesiaNeurodyniaPainTrauma

Interventions

DRUG

GW406381

Trial Locations (5)

G12 0YN

GSK Investigational Site, Glasgow

L9 7AL

GSK Investigational Site, Liverpool

LE1 5WW

GSK Investigational Site, Leicester

B91 2JL

GSK Investigational Site, Solihull

W12 0NN

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY